Epsilon M&A Deal Report - Animal Health Business of Novartis AG (Novartis AH)
Transaction Multiples for the Valuation of Private Companies
Eli Lilly and Company / Animal Health Business of Novartis AG (Novartis AH)
No EMAT :
72769
Announced Date :
22/04/2014
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Eli Lilly and Company
Target :
Animal Health Business of Novartis AG (Novartis AH)
Country :
Switzerland
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Veterinary Pharmaceuticals
Business Description :
Novartis AH business consists of the research and development, manufacture, marketing, sale and distribution of veterinary products. > Products are used to prevent and treat diseases in: pets:...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|||||||
| Current |
|
|
|
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Veterinary Pharmaceuticals » = 34
| Date | Acquirer | Target | Country | Multiples | See details |
| 31/10/2005 | Private Group led by Genstar Capital LLC | Harlan Sprague Dawley | United States | * | 72762 |
| 11/06/2015 | Altan Pharma | GES Group | Spain | ** | 72544 |
Source: Epsilon Research / EMAT
